PanCareSurPass Project HL7 FHIR Implementation Guide
0.2.0 - CI Build 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

ValueSet: Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp Version: 0.2.0
Draft as of 2025-08-02 Computable Name: RiskCondition

Condition at risk proposed by the PCSP algorithm

References

Logical Definition (CLD)

 

Expansion

Expansion performed internally based on codesystem PCSP Conditions at risk v0.2.0 (CodeSystem)

This value set contains 47 concepts

CodeSystemDisplay (en-US)Definition
  1http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent thyroid cancerSubsequent thyroid cancer
  2http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent breast cancerSubsequent breast cancer
  3http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
  4http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspImpaired fertility Impaired spermatogenesisImpaired fertility Impaired spermatogenesis
  5http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspTestosterone deficiencyTestosterone deficiency
  6http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPhysical sexual dysfunctionPhysical sexual dysfunction
  7http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPremature ovarian insufficiencyPremature ovarian insufficiency
  8http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspEar problemsEar problems
  9http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspImpaired glucose metabolism and diabetes melitusImpaired glucose metabolism and diabetes melitus
  10http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspDyslipidemiaDyslipidemia
  11http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspOverweight and obesityOverweight and obesity
  12http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypertensionHypertension
  13http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspReduced bone mineral densityReduced bone mineral density
  14http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspOsteonecrosisOsteonecrosis
  15http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
  16http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
  17http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCentral precocious puberty (CPP) For girls with age below 8 yearsCentral precocious puberty (CPP) For girls with age below 8 years
  18http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCentral precocious puberty (CPP) For boys with age below 9 yearssCentral precocious puberty (CPP) For boys with age below 9 yearss
  19http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspThyroid function problemsThyroid function problems
  20http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCerebrovascular problemCerebrovascular problem
  21http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspNeurocognitive problemsNeurocognitive problems
  22http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPeripheral neuropathyPeripheral neuropathy
  23http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCataractCataract
  24http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspEye problemsEye problems
  25http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCraniofacial growth problemsCraniofacial growth problems
  26http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSpine scoliosis and kyphosisSpine scoliosis and kyphosis
  27http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspLower urinary tract problemsLower urinary tract problems
  28http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspObstetric problemsObstetric problems
  29http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspDental and oral problemsDental and oral problems
  30http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspGastro-intestinal problemsGastro-intestinal problems
  31http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspArrhythmiaArrhythmia
  32http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPulmonary problemsPulmonary problems
  33http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspRenal problems (Glomerular dysfunction - Tubular dysfunction)Renal problems (Glomerular dysfunction - Tubular dysfunction)
  34http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspLiver problemsLiver problems
  35http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspIron overloadIron overload
  36http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSpleen problemsSpleen problems
  37http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspTumor predispositionTumor predisposition
  38http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent melanoma and non-melanoma skin cancerSubsequent melanoma and non-melanoma skin cancer
  39http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent colorectal cancerSubsequent colorectal cancer
  40http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent Oral CancerSubsequent Oral Cancer
  41http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent acute myeloid leukaemia or myelodysplasiaSubsequent acute myeloid leukaemia or myelodysplasia
  42http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent bladder cancerSubsequent bladder cancer
  43http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent Bone CancerSubsequent Bone Cancer
  44http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent lung cancerSubsequent lung cancer
  45http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent CNS neoplasmsSubsequent CNS neoplasms
  46http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
  47http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspRenal problems (Tubular dysfunction)Renal problems (Tubular dysfunction)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code